Age and Ageing

Real-world effectiveness of SGLT2 inhibitors in adults aged 75 years or older: a target trial emulation

Cohort study of 8,486 peopleInterventions

The paper

The Graduate University for Advanced Studies, SOKENDAI; Kyushu University

Age and Ageing, 3 Aug 2026

doi.org/10.1093/ageing/afag246PubMed 42613674